Z ZAI LAB LTD
| Market Cap | $2.11B |
| P/E Ratio | — |
| Forward P/E | -13.17 |
| Dividend Yield | — |
| Beta | 0.88 |
| 52W Range | $15.96 - $44.34 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 29 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Edmondson Frazor Titus IIIChief Legal Officer | Sale | 4,194 | $20.39 | $85.52K | 02 Apr 2026 | 04 Mar 2026 |
| Chen YajingChief Financial Officer | Sale | 5,199 | $20.39 | $106.01K | 02 Apr 2026 | 04 Mar 2026 |
| Du YingChairperson & CEO | Sale | 5,576 | $20.39 | $113.69K | 02 Apr 2026 | 04 Mar 2026 |
| Amado RafaelSee Remarks | Sale | 9,910 | $20.39 | $202.06K | 02 Apr 2026 | 04 Mar 2026 |
| Smiley Joshua LSee Remarks | Sale | 9,614 | $20.39 | $196.03K | 02 Apr 2026 | 04 Mar 2026 |
| GAYNOR RICHARD | Buy | 1,731 | $18.91 | $32.73K | 17 Mar 2026 | 17 Mar 2026 |
| Edmondson Frazor Titus IIIChief Legal Officer | Sale | 1,281 | $18.63 | $23.86K | 13 Mar 2026 | 04 Mar 2026 |
| Amado RafaelSee Remarks | Sale | 2,957 | $18.63 | $55.08K | 13 Mar 2026 | 04 Mar 2026 |
| Chen YajingChief Financial Officer | Sale | 1,703 | $18.63 | $31.72K | 13 Mar 2026 | 04 Mar 2026 |
| Smiley Joshua LSee Remarks | Sale | 1,966 | $18.63 | $36.62K | 13 Mar 2026 | 04 Mar 2026 |
| Du YingChairperson & CEO | Sale | 1,067 | $19.08 | $20.36K | 11 Mar 2026 | 10 Mar 2026 |
| Du YingChairperson & CEO | Sale | 50,000 | $19.03 | $951.47K | 09 Mar 2026 | 06 Mar 2026 |
| Du YingChairperson & CEO | Sale | 50,000 | $19.42 | $970.93K | 06 Mar 2026 | 06 Mar 2026 |
| Du YingChairperson & CEO | Sale | 50,000 | $19.22 | $961.05K | 05 Mar 2026 | 06 Mar 2026 |
| Edmondson Frazor Titus IIIChief Legal Officer | Sale | 15,569 | $19.06 | $296.75K | 05 Mar 2026 | 06 Mar 2026 |
| Ying DuChairperson & CEO | Sale | 50,000 | $19.22 | $961.05K | 05 Mar 2026 | 06 Mar 2026 |
| Frazor Titus Edmondson IIIChief Legal Officer | Sale | 15,569 | $19.06 | $296.75K | 05 Mar 2026 | 06 Mar 2026 |
| Du YingChairperson & CEO | Sale | 35,710 | $19.32 | $689.83K | 04 Mar 2026 | 06 Mar 2026 |
| Du YingChairperson & CEO | Sale | 14,290 | $18.78 | $268.32K | 04 Mar 2026 | 06 Mar 2026 |
| Ying DuChairperson & CEO | Sale | 35,710 | $19.32 | $689.83K | 04 Mar 2026 | 06 Mar 2026 |
| Ying DuChairperson & CEO | Sale | 14,290 | $18.78 | $268.32K | 04 Mar 2026 | 06 Mar 2026 |
| Amado RafaelSee Remarks | Sale | 10,000 | $17.38 | $173.80K | 03 Mar 2026 | 05 Mar 2026 |
| Amado RafaelSee Remarks | Sale | 10,787 | $17.43 | $188.04K | 31 Dec 2025 | 02 Jan 2026 |
| Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 10,787 | $17.43 | $188.04K | 31 Dec 2025 | 02 Jan 2026 |
| Edmondson Frazor Titus IIIChief Legal Officer | Sale | 8,651 | $17.14 | $148.28K | 16 Dec 2025 | 18 Dec 2025 |
| Edmondson Frazor Titus IIIChief Legal Officer | Sale | 14,328 | $19.78 | $283.41K | 21 Nov 2025 | 25 Nov 2025 |
| Frazor Titus Edmondson IIIChief Legal Officer | Sale | 14,328 | $19.78 | $283.41K | 21 Nov 2025 | 25 Nov 2025 |
| Chen YajingChief Financial Officer | Sale | 240 | $26.83 | $6.44K | 03 Nov 2025 | 04 Nov 2025 |
| Yajing ChenChief Financial Officer | Sale | 240 | $26.83 | $6.44K | 03 Nov 2025 | 04 Nov 2025 |
Frequently Asked Questions
What is ZLAB stock price today?
ZAI LAB LTD (ZLAB) is currently trading at $19.05. The stock has a 52-week range of $15.96 to $44.34 and a market capitalization of $2.11B.
Is ZLAB a good stock to buy in 2026?
ZAI LAB LTD has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -44.9%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ZLAB stock?
There have been 29 insider transactions for ZLAB in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ZLAB stock performed over the past year?
ZAI LAB LTD (ZLAB) has returned -44.9% over the past 12 months. The stock traded between $15.96 and $44.34 during this period, and is currently at $19.05.
Which hedge funds own ZLAB (ZAI LAB LTD)?
0 tracked hedge funds currently hold ZLAB in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ZLAB's market cap and valuation?
ZAI LAB LTD (ZLAB) has a market capitalization of $2.11B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is ZLAB's revenue and profitability?
ZAI LAB LTD reported revenue of $460.16M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.88.
What sector is ZLAB in and who are its biggest institutional holders?
ZAI LAB LTD (ZLAB) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.